×
ADVERTISEMENT

Lumakras

FDA Approves Lumakras With Vectibix for KRAS G12C–Mutated Colorectal Cancer

The FDA has approved Lumakras with Vectibix for adult patients with KRAS G12C–mutated metastatic colorectal ...

JANUARY 21, 2025

FDA Approves First KRAS-Targeted Therapy, Lumakras, for NSCLC

The FDA granted accelerated approval to the RAS GTPase inhibitor sotorasib (Lumakras, Amgen) for the treatment of ...

JUNE 7, 2021

Load more